MEDICAL DEVICES News & Analysis

Morningstar analyst Shane Ponraj discusses the latest clinical trial results from Eli Lilly.

Despite advancing from its October low, the undervalued stock of this narrow-moat company may have more room to run.

Analysts say the incident has given the medical device company a 'rare opportunity’ to expand its market share.

Covid's winners and losers are returning to their prior trajectories. 

A return to normal has increased the incidence of burns and that means business for the spray-on-skin maker.

The single-product company is high-risk, high-reward.

It’s the leader in medical device disinfection but patent expiry and the potential for copycats raise doubts, says Nicolette Quinn. 

The corona sell-off hurt the spray-on-skin maker but it’s got an eye on the bigger picture, says Nicolette Quinn

Spray-on skin maker Avita Medical has a chance of becoming the new standard in burns treatment, says Morningstar's Nicolette Quinn. 

3D Printing, Bioinformatics and Financial Services Innovation are set for exponential growth in coming years. In the final part of our series, we...